Artificial Intelligence is a disruptive force in healthcare, revolutionising it through automated medical imaging like X-rays, MRIs, and CT scans. It promises faster, more accurate diagnoses, lowers costs, and enables personalised treatment. AI medical imaging company CurveBeam AI (proposed ASX: CVB) embodies this development, bringing into the table its weight-bearing CT scanner HiRise as it
Read More
Individuals around the world will soon have more opportunities to win $500 million jackpots with online lottery platform AZBillions to deploy digital humans to its online ticketing platform, powered by artificial intelligence company UNITH (ASX: UNT). The purchase order from Xite Holdings, which wholly-owns and operates AZBillions, which will deploy the digital humans to perform
Read More
If left untreated, aortic stenosis, i.e. heart valve disease, carries a high 2-5 year mortality rate. What’s more, fewer women compared to men receive an accurate diagnosis of the disease. So, in a matter of life and death, artificial intelligence (AI) shines through, with AI and MedTech company Echo IQ (ASX: EIQ) having found a
Read More
Quantum computing has emerged as a cutting-edge field with the potential to revolutionise various aspects of technology, from cryptography and optimisation to drug discovery and artificial intelligence. One critical factor that plays a pivotal role in the performance of quantum computers is the conditions in which their qubit processors are required to operate. They include
Read More
AI solutions provider for healthcare companies Beamtree Holdings (ASX: BMT) has won a significant contract bid with the Provincial Health Services Authority (PHSA) in British Columbia, Canada. This milestone marks Beamtree’s first major foray into the North American market. The contract, valued at approximately $0.5 million, signifies a pivotal achievement for the Company and is
Read More
As medical technology continues to advance, digital imaging is now a staple for image interpretation for cancer diagnosis, especially in finding potential abnormalities that aren’t visible to the eyes as well as evaluating the extent of the disease. Breast cancer software company Volpara (ASX: VHT) is among those that offers what it takes to meet
Read More